The increasing prevalence of cataracts, particularly among the aging population, serves as a significant driver for the global multifocal intraocular lenses (IOLs) market. As cataracts remain the leading cause of blindness and visual impairment worldwide, the demand for effective and long-lasting solutions has surged. Multifocal IOLs offer a compelling alternative to traditional monofocal lenses by enabling patients to focus at multiple distances without the need for additional corrective eyewear. This capability is particularly appealing to a growing demographic of older adults who wish to maintain an active lifestyle post-cataract surgery. With the global population aging and the incidence of cataracts rising in tandem, healthcare providers and patients alike are increasingly turning to advanced multifocal IOLs to restore clear vision across different focal points. Furthermore, technological advancements in lens design, such as improved light distribution and reduced halos and glare, have enhanced patient outcomes, driving greater adoption. The convergence of these factors, coupled with an increasing awareness of the benefits of multifocal IOLs, is propelling market growth as more individuals opt for these innovative lenses to improve their quality-of-life following cataract surgery.
The rising prevalence of cataracts, especially among the elderly, is fueling the global demand for multifocal IOLs. As more people seek to restore clear vision at multiple distances after cataract surgery, the appeal of these advanced lenses grows. Coupled with technological improvements and increased awareness, multifocal IOLs are becoming a preferred choice, driving market expansion as they offer a significant enhancement to patients' post-surgery quality of life.
Access Full Report @ https://www.databridgemarketresearch.com/reports/global-multifocal-iols-market
Data Bridge Market Research analyzes that the Global Multifocal IOLs Market is expected to reach USD 1.93 billion by 2031 from USD 1.21 billion in 2023, growing with a CAGR of 6.4% in the forecast period of 2024 to 2031.
Key Findings of the Study
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2024 to 2031
|
|
Base Year
|
2023
|
|
Historic Years
|
2022 (Customizable 2016-2021)
|
|
Quantitative Units
|
Revenue in USD Billion
|
|
Segments Covered
|
Type (Soft Lens and Rigid Gas Permeable (RGP, or Hard) Lens), Design (Simultaneous Vision Lenses and Segmented Multifocal Lenses), Packaging (Pack of 6, Pack of 30, and Others), Product Type (Diffractive Multifocal IOLs, Hybrid Multifocal IOLs and Refractive Multifocal IOLs), Brand (Technis Symphony, Zeiss Trifocal, and Others), Incision Size (1.8 MM, 2.2 MM, and Others), Pupil Dependence (Dependent and Independent), Power (Low Power and High Power), Material (Hydrophobic Acrylic, Silicon & Collamer, Lehfilcon-A, Somofilcon A and Others), Adjustability (Light Reduction and Non Reduction), Price Range (Premium Lens and Standard Lens), Flexibility (Foldable IOLs and Rigid IOLs), Age Group (Above 51 Years, 41-50 Years and Below 40 Years), Gender (Female and Male), Application (Vision Disorder, Cataract, Corneal Disorder, and Others), End User (Hospitals, Ophthalmology Clinics, Eye Research Institutes, Ambulatory Surgery Centers and Others), Distribution Channel (Direct Tender, Retail Sales and Others)
|
|
Countries Covered
|
China, India, Australia, South Korea, Japan, Indonesia, Malaysia, Singapore, Thailand, Philippines, Vietnam, Rest of Asia-Pacific, Brazil, Argentina, Peru, Rest of South America, France, Germany, U.K., Italy, Spain, Russia, Switzerland, Netherlands, Hungary, Lithuania, Turkey, Ireland, Austria, Poland, Norway, Rest of Europe, U.S., Canada, Mexico, South Africa, U.A.E., Egypt, Kuwait, Israel, and Rest of Middle East and Africa
|
|
Market Players Covered
|
Zeiss Group (Germany), Hoya Medical Singapore Pte. Ltd. Or its affiliates (Japan), Johnson & Johnson Services Inc. (U.S.), ALCON INC. (Switzerland), RAYNER GROUP (U.K.), AUROLAB, EXCELLENT HI-CARE PVT. LTD. (U.K.), HANITA LENSES LTD. (Israel), IOLART (Greece), LENSTEC INC. (U.S.), Omni Lens (India), Ophtec BV (Netherlands), SAV-IOL SA (Europe), VSY BIOTECHNOLOGY GMBH (Europe) among others
|
|
Data Points Covered in the Report
|
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include in-depth expert analysis, patient epidemiology, pipeline analysis, and regulatory framework
|
Segment Analysis
Global multifocal IOLs market is categorized into seventeen notable segments which are based on the type, design, packaging, product type, brand, incision size, pupil dependence, power, material, adjustability, price range, flexibility, age group, gender, application, end user and distribution channel.
- On the basis of type, the market is segmented into soft lens and Rigid Gas Permeable (RGP, or Hard) lens
In 2024, the soft lens segment is expected to dominate the global multifocal IOL market
In 2024, the soft lens segment is expected to dominate the market with a market share of 63.62% due to growing healthcare needs.
- On the basis of design, the market is segmented into simultaneous vision lenses and segmented multifocal lenses
In 2024, the simultaneous vision lens segment is expected to dominate the global multifocal IOL market
In 2024, the simultaneous vision lens segment is expected to dominate the market with a market share of 61.45% due to the increasing cataract disorders.
- On the basis of packaging, the market is segmented into pack of 6, pack of 30, and others. In 2024, pack of 6 segment is expected to dominate the market with a market share of 51.24%
- On the basis of product type, the market is segmented into diffractive multifocal IOLs, hybrid multifocal IOLs, and refractive multifocal IOLs. In 2024, diffractive multifocal IOLs segment is expected to dominate the market with a market share of 52.06%
- On the basis of brand, the market is segmented into technis symphony, zeiss trifocal and others. In 2024, technis symphony segment is expected to dominate the market with a market share of 49.55%
- On the basis of incision size, the market is segmented into 1.8 MM, 2.2 MM, and others. In 2024, 1.8MM segment is expected to dominate the market with a market share of 56.23%
- On the basis of pupil dependence, the market is segmented into dependent and independent. In 2024, dependent segment is expected to dominate the market with a market share of 78.04%
- On the basis of power, the market is segmented into low power and high power. In 2024, low power segment is expected to dominate the market with a market share of 63.60%
- On the basis of material, the market is segmented into hydrophobic acrylic, silicon & collamer, lehfilcon-A, somofilcon A, and others. In 2024, hydrophobic acrylic segment is expected to dominate the market with a market share of 42.22%
- On the basis of adjustability, the market is segmented into light reduction and non reduction. In 2024, light reduction segment is expected to dominate the market with a market share of 60.61%
- On the basis of price range, the market is segmented into premium lens and standard lens. In 2024, premium lens segment is expected to dominate the market with a market share of 79.20%
- On the basis of flexibility, the market is segmented into foldable IOLs and rigid IOLs. In 2024, foldable IOLs segment is expected to dominate the market with a market share of 75.16%
- On the basis of age group, the market is segmented into Above 51 years, 41-50 years, and below 40 years. In 2024, above 51 years segment is expected to dominate the market with a market share of 53.06%
- On the basis of gender, the market is segmented into female and male. In 2024, female segment is expected to dominate the market with a market share of 59.16%
- On the basis of application, the market is segmented into vision disorder, cataract, corneal disorder, and others. In 2024, vision disorder segment is expected to dominate the market with a market share of 43.99%
- On the basis of end user, the market is segmented into hospitals, ophthalmology clinics, eye research institutes, ambulatory surgery centers, and others. In 2024, hospitals segment is expected to dominate the market with a market share of 44.10%
- On the basis of distribution channel, the market is segmented into direct tender, retail sales, and others. In 2024, direct tender segment is expected to dominate the market with a market share of 56.66%
Major Players
Data Bridge Market Research analyzes Zeiss Group (Germany), Hoya Medical Singapore Pte. Ltd. Or its affiliates (Japan), Johnson & Johnson Services Inc. (U.S.), ALCON INC. (Switzerland), RAYNER GROUP (U.K.) as major market players in this market.
Market Developments
- In February 2024, VSY Biotechnology GmbH, a leading company in biotechnology, is set to unveil its innovative ophthalmic product, the Enova Maestro - Sinusoidal Trifocal Toric Preloaded IOL, at the upcoming ESCRS Winter Meeting. The event, taking place from February 15 to 18, 2024, at the Congress Centre Messe Frankfurt in Germany, will be a significant milestone for VSY Biotechnology. The Enova Maestro is made from 100% glistening-free hydrophobic acrylic material and is designed to provide outstanding vision at all distances—far, intermediate, and near—under various lighting conditions
- In March 2023, The ZEISS Group design and innovate IOL and OVD Portfolio to address both patient needs and surgeon preferences. Combining innovation and precision, it offers a comprehensive selection of cataract consumables and implants, tailored for monofocal, toric, and refractive cataract surgeries
- In February 2020, Janssen Pharmaceutical Companies of Johnson & Johnson Services, Inc. stated the submission of a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) seeking sanction of DARZALEX in combination with Kyprolis and dexamethasone for relapsed/refractory multiple myeloma. If approved this will increase the product portfolio and also revenue generation of the company
- In March 2024, Alcon, the global leader in eye care dedicated to helping people see brilliantly, today proudly announces AcrySof IQ, Vivity and Clareon. Vivity extended depth of focus (EDOF) intraocular lenses (IOLs) have surpassed more than one million implants worldwide. Vivity is the most implanted EDOF IOL globally. Alcon is the global leader in IOLs—every four seconds an eye is implanted with an Alcon IOL—and continues to innovate in this space to address patients’ unmet needs
Regional Analysis
Geographically, the countries covered in the global multifocal IOL market report are China, India, Australia, South Korea, Japan, Indonesia, Malaysia, Singapore, Thailand, Philippines, Vietnam, rest of Asia-Pacific, Brazil, Argentina, Peru, rest of South America, France, Germany, U.K., Italy, Spain, Russia, Switzerland, Netherlands, Hungary, Lithuania, Turkey, Ireland, Austria, Poland, Norway, rest of Europe, U.S., Canada, Mexico, South Africa, U.A.E., Egypt, Kuwait, Israel, and rest of Middle East and Africa.
As per Data Bridge Market Research analysis:
North America is expected to dominate and fastest growing region in global multifocal IOLs market
North America is expected to dominate and fastest growing region in this market due to robust initiatives taken by government. The region's increasing number of consumers in the market contribute to a strong demand for multifocal IOLs.
For more detailed information about the global multifocal IOLs market report, click here – https://www.databridgemarketresearch.com/reports/global-multifocal-iols-market
